Pharmaceutical Industry Professional Development

Recorded Webinars from our 2020 Immunology Series Available

These 4, 1 hour recorded webinars are FREE and intended for pharmacists interested in an in-depth study of Immunology and Immune mechanisms in Cancer and Cancer Treatments.  Our speakers, have no relevant financial interests to disclose regarding these topics.

After viewing any one or ALL of the recorded webinars below, go to our Log In Page and type in your NABP ID, DOB and the session code listed below each title to complete the quiz and evaluation to receive your CE credit.

Immune Mechanisms in Cancer Therapy - 1 hour
Dr. Andrea K. Hubbard, Associate Professor; UCONN School of Pharmacy, Storrs, CT
Release Date:  September 9, 2020
Expiration Date: September 9, 2023
Session Code: 20RC52-ABC36

At the conclusion of this presentation, participants will be able to:

1. Discuss basic principles of tumor cell biology and carcinogenesis
2. Discuss basic principles of tumor immune surveillance, tumor escape mechanisms and the mechanistic stages of intervention
3. Describe mechanisms underlying efficacy and modifications of monoclonal antibodies and immunotoxins in therapy
4. Identify toxicities associated with monoclonal antibody therapy
5. Describe the clinical management of monoclonal antibody therapy toxicities
   ACPE UAN:  0009-0000-20-052-H01-P

Tumor Immunotherapy: Checkpoint Inhibitors - 1 hour
Dr. Trinh Pham, Oncology Pharmacist, Smilow Cancer Hospital, New Haven, CT
Release Date:  September 16, 2020
Expiration Date: September 16, 2023
Session Code:  20RC53-CBA37

At the conclusion of this presentation, participants will be able to:

1. Describe the mechanisms underlying immune checkpoint inhibitors
2. Describe the role of immune checkpoint inhibitors in various cancer types
3. Describe the evolving role of biomarkers used to predict response to this immunotherapy
4. Identify monitoring parameters for immune-related adverse effects (irAEs) associated with immune checkpoint inhibitors
5. Identify appropriate clinical management of immune checkpoint inhibitor irAEs
   ACPE UAN:  0009-0000-20-053-H01-P

Tumor Immunotherapy: Tumor Vaccines - 1 Hour
Dr. Andrea K. Hubbard, Associate Professor; UCONN School of Pharmacy, Storrs, CT
Release Date:  September 23, 2020
Expiration Date: September 23, 2023
Session Code: 20RC54-XTW83

At the conclusion of this presentation, participants will be able to:

1. Discuss basic steps in creating tumor vaccines to include personalized tumor vaccines, cancer DNA vaccines, and autologous dendritic cell vaccines
2. Describe vaccines of oncoviral therapy (oncolytic T‐VEC therapy) in select malignancies
3. Describe the clinical application and ongoing clinical trials of therapeutic cancer vaccines
4. Identify toxicities associated with tumor vaccine therapy
5. Describe the clinical management of tumor vaccine toxicities
   ACPE UAN:  0009-0000-20-054-H06-P

Tumor Immunotherapy: Chimeric Antigen Receptor (CAR) T Cell Therapy - 1 Hours
Dr. Trinh Pham, Oncology Pharmacist, Smilow Cancer Hospital,  New Haven CT
Release Date:  September 30, 2020
Expiration Date: September 30, 2023
Session Code:  20RC55-WTX94

At the conclusion of this presentation, participants will be able to:

1. Describe the mechanisms underlying CAR-T cell therapy
2. Describe the role of CAR T-cell therapy in B-cell malignancies
3. Discuss the development of CAR T-cell therapy for solid tumors
4. Identify toxicities associated with CAR-T cell therapy
5. Describe the clinical management of CAR-T cell toxicities
   ACPE UAN:  0009-0000-20-055-H01-P

A grant was provided for partial funding of the above activities by Bristol Meyers Squibb.

The University of Connecticut School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  To receive CE credit the learner must view the above recorded webinars, pass an exam with a 70% or better and submit an evaluation of the program.